TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL — image 1 of 3

Product details

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL

Catalog number BNUB2059-500

Price for BNUB2059-500

Size / count 1x 500 µL

About this product

VEGI is an anti-angiogenic cytokine that belongs to tumor necrosis factor superfamily, member 15 (TNFSF15) . This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Reduced expression of VEGI has been reported as a marker of poor prognosis in breast cancer.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNUB2059-500
Size / count: 1x 500 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: TNF ligand-related molecule 1 (TL1A) ; Tumor necrosis factor (ligand) superfamily member 15 (TNFSF15) ; Vascular endothelial growth inhibitor 192a; Vascular endothelial growth inhibitor (VEGI) ; VEGI192A
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: TNFSF15
Gene ID: 9966
NCBI Gene ID: 241382
UniProt: O95150
Swiss Prot: O95150
Host: Mouse
Species Reactivity: Human
Reactivity: TNFS15|VEGI
Immunogen: Recombinant full-length human VEGI protein
Target Antigen: TNFS15 | VEGI
Clonality: Recombinant Monoclonal
Clone: RVEGI/1283
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Angiogenesis, Cytokines
Positive Control: Endothelial cells. Colon, intestine, placenta, lung, liver, kidney, pancreas, spleen and prostate.
Stability: 2 years
Concentration: 0.2 mg/mL
Buffer: PBS, 0.05% BSA, 0.05% azide
Molecular Weight: 22 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate: Purified, with BSA

Frequently Asked Questions

What is the catalog number for TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL?

The catalog number for TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL is BNUB2059-500.

What sizes are available for TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL?

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL is available in the following size(s): 1x 500 µL.

Is TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL in stock?

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL?

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL?

Estimated delivery time for TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL?

The safety data sheet for TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), 0.2mg/mL used for?

Is this product species cross-reactive?

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Is there an additional fee for hazardous or dry ice shipping of this product?

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

How many freeze-thaw cycles can this product tolerate?

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.